MoonLake Immunotherapeutics

Q4 2024 13F Holders

Symbol
MLTX
CUSIP
61559X104
Type
Equity
Class
CLASS A ORD
Num filings
130
Total reported value, excl. options
$3.42 B
Manager Report Date Value ($000) Shares Option Type